Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04101994
Other study ID # 201701518A0
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 26, 2018
Est. completion date June 6, 2022

Study information

Verified date July 2021
Source Chang Gung Memorial Hospital
Contact Chia-Ling Chen, MD, PhD
Phone +886-3-3281200
Email clingchen@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cerebral palsy (CP) is the most common childhood motor disability. Weakness, spasticity, and loss of dexterity are the major problems in patients with CP. A novel virtual-reality cycling training (VCT) program was to enhance promising muscle strength and motor function through promoting the participant compliance and motivation. Non-invasive brain stimulation (NIBS), such as repetitive transcranial magnetic stimulation (rTMS) and transcranial electric stimulation (TES) has potential to augment the training effects in motor neurorehabilitation via the modulation on neuroplasticity. Therefore, this study propose a novel intervention protocol to induce superior benefits on upper extremity (UE) motor function in patients with CP.


Description:

This study aims to investigate the augmented effects of VCT on neuromotor control and UE motor function by NIBS in patients with CP. We hypothesize that NIBS can augment the VCT effects on neuromotor control and UE motor function in patients with CP because combined therapy integrated peripheral modification techniques (VCT) and central modulation (NIBS). These effects may further enhance the activity of daily living (ADL), participation, and health related quality of life (HRQOL). This project is executed in the following two phases: to investigate the augmented effects of VCT on neuromotor control and UE motor function in patients with CP by rTMS in phase 1 (0-1.5 years) and tCS in phase 2 (1.5-3 years).


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date June 6, 2022
Est. primary completion date March 6, 2022
Accepts healthy volunteers No
Gender All
Age group 5 Years to 20 Years
Eligibility Inclusion Criteria: - Diagnosis of CP according to clinical criteria - Age 5-20 years - No use of botulinum toxin in the past 4 months - No significant perceptual or communication disturbances - No other peripheral or central nervous system dysfunction - No active inflammatory or pathologic changes in upper limb joints during the previous 6 months - No active medical problems, such as pneumonia, upper gastrointestinal bleeding, or urinary tract infection - No active problems of epilepsy and EEG without epileptiform discharge Exclusion Criteria: - Metabolic disorders, such as inborn error of metabolism, electrolyte, and endocrine disorders - Active infectious disease, such as meningitis and encephalitis - Patients with active medical problems, such as pneumonia, upper gastrointestinal bleeding, or urinary tract infection - Poor compliance or intolerance for the TMS therapy - Subjects with metallic implants or pregnancy. - EEG show epileptiform discharge - Patients with family history of epilipsy - Patients with symptoms that are restricted from tDCS, such as epilepsy, migraine and unstable health condition

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Virtual cycling training
Virtual cycling training is a convenient and easy approach for muscle strengthening.
Repetitive transcranial magnetic stimulation
Intermittent theta burst stimulation produces short TBS trains intermittently to facilitate cortical excitability.
Transcranial electric stimulation
TES is a constant current with low intensity delivered to the skull through surface electrodes.

Locations

Country Name City State
Taiwan Chang Gung Memorial Hospital Taoyuan

Sponsors (1)

Lead Sponsor Collaborator
Chang Gung Memorial Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline Bruininks- Oseretsky Test of Motor Proficiency II at after six weeks of treatment and three month The Bruininks- Oseretsky Test of Motor Proficiency II (BOT-2) provides an overview of fine and gross motor skills in children and school-aged adolescents. baseline, after 6 weeks of treatment, 3 months
Primary Change from baseline Goal Attainment Scale at after six weeks of treatment and three month Goal Attainment Scale (GAS) is used to help a person with cerebral palsy and their family develop personal goals for therapy (for each item minimum value is -2 and maximum value is 2, higher scores mean a better outcome). baseline, after 6 weeks of treatment, 3 months
Secondary Change from baseline Melbourne Assessment 2 at after six weeks of treatment and three month The Melbourne Assessment 2 (MA2) is a valid and reliable tool for evaluating quality of upper limb movement in children with a neurological impairment aged 2.5 to 15 years. baseline, after 6 weeks of treatment, 3 months
Secondary Change from baseline Quality of upper extremity skills test at after six weeks of treatment and three month The Quality of upper extremity skills test (QUEST) is an outcome measure that evaluates movement patterns and hand function in children with cerebral palsy. baseline, after 6 weeks of treatment, 3 months
Secondary Change from baseline Box and block test at after six weeks of treatment and three month The Box and Block Test (BBT) measures unilateral gross manual dexterity. baseline, after 6 weeks of treatment, 3 months
Secondary Change from baseline Nine-Hole test at after six weeks of treatment and three month The Nine-Hole Peg Test (NHPT) is used to measure finger dexterity in patients with various neurological diagnoses. baseline, after 6 weeks of treatment, 3 months
Secondary Change from baseline Functional Independence Measure at after six weeks of treatment and three month Functional Independence Measure for Children:Applicable to infants and adolescents. The main purpose is to understand and track children's life function performance, progress and goal achievement. There are three main areas: self-care, mobility, and cognition. The score is from 1 to 7 points, 1 is completely dependent, and 7 is completely independent. baseline, after 6 weeks of treatment, 3 months
Secondary Change from baseline Pediatric Motor Activity Log at after six weeks of treatment and three month The Pediatric Motor Activity Log (PMAL) is a structured interview intended to examine how often and how well a child uses his/her involved upper extremity (UE) in their natural environment outside the therapeutic setting. baseline, after 6 weeks of treatment, 3 months
Secondary Change from baseline ABILHAND Questionnaire at after six weeks of treatment and three month The ABILHAND questionnaire assesses bimanual ability as an interview-based test focused on the patient's perceived difficulty. The ABILHAND-KIDS questionnaire is filled in by the parent of the child by rating the child's perceived difficulty of bimanual activities. baseline, after 6 weeks of treatment, 3 months
Secondary Change from baseline Assessment of Preschool Children's Participation at after six weeks of treatment and three month Preferences for Activity of Children(APCP): For children between the ages of two and five, the questionnaire model is used to allow parents to circle the level. There are 45 questions in total, so that the case or parent can review the activities in the past 4 months and ask if the child have done this activity (1 point means yes, 0 points means no). baseline, after 6 weeks of treatment, 3 months
Secondary Change from baseline Children Assessment of Participation and Enjoyment at after six weeks of treatment and three month Children Assessment of Participation and Enjoyment(CAPE): Applicable to children or adolescents between the ages of six and twenty one, through questionnaires through self-reports or interviews, a total of 55 questions, asking children about the activities involved in the past four months (1 point for yes, 0 for no). baseline, after 6 weeks of treatment, 3 months
Secondary Change from baseline Cerebral Palsy Quality of Life at after six weeks of treatment and three month The comparison of baseline of Cerebral Palsy Quality of Life for CP after different therapy. baseline, after 6 weeks of treatment, 3 months
Secondary Change from baseline Motor Evoked Potential at after six weeks of treatment and three month The comparison of baseline of Motor Evoked Potential for CP after different therapy. baseline, after 6 weeks of treatment, 3 months
Secondary Change from baseline Myoton at after six weeks of treatment and three month The comparison of baseline of Myoton for CP after different therapy. baseline, after 6 weeks of treatment, 3 months
Secondary Change from baseline Hand dynamometer at after six weeks of treatment and three month The comparison of baseline of hand dynamometer for CP after different therapy. baseline, after 6 weeks of treatment, 3 months
Secondary Change from baseline Motion analysis at after six weeks of treatment and three month All participants will be instructed to perform a series of upper-extremity tasks. The tasks include reaching and grasping. An 8-camera motion analysis system (Vicon system, 3-D Oxfort Metrics Ltd, Oxford, UK) is used in conjunction with a personal computer to capture the movement of markers placed on the participant's body; analog signals were collected simultaneously. Movements were recorded at 120 Hz and digitally low-pass filtered at 5 Hz using a second-order Butterworth filter. Reference markers are placed on the distal interphalangeal joints of the thumb and index finger, the styloid process of the ulna, proximal end of the second metacarpal, and the object. baseline, after 6 weeks of treatment, 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT05317234 - Genetic Predisposition in Cerebral Palsy N/A
Recruiting NCT05576948 - Natural History of Cerebral Palsy Prospective Study
Completed NCT04119063 - Evaluating Wearable Robotic Assistance on Gait Early Phase 1
Completed NCT03264339 - The Small Step Program - Early Intervention for Children With High Risk of Developing Cerebral Palsy N/A
Completed NCT05551364 - Usability and Effectiveness of the ATLAS2030 Exoskeleton in Children With Cerebral Palsy N/A
Completed NCT03902886 - Independent Walking Onset of Children With Cerebral Palsy
Recruiting NCT05571033 - Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy N/A
Not yet recruiting NCT04081675 - Compliance in Children With Cerebral Palsy Supplied With AFOs
Completed NCT02167022 - Intense Physiotherapies to Improve Function in Young Children With Cerebral Palsy N/A
Completed NCT04012125 - The Effect of Flexible Thoracolumbar Brace on Scoliosis in Cerebral Palsy N/A
Enrolling by invitation NCT05619211 - Piloting Movement-to-Music With Arm-based Sprint-Intensity Interval Training Among Children With Physical Disabilities Phase 1
Completed NCT04489498 - Comparison of Somatometric Characteristics Between Cerebral Palsy and Normal Children, Cross-sectional, Multi Center Study
Completed NCT03677193 - Biofeedback-enhanced Interactive Computer-play for Youth With Cerebral Palsy N/A
Recruiting NCT06450158 - Robot-assisted Training in Children With CP N/A
Completed NCT04093180 - Intensive Neurorehabilitation for Cerebral Palsy N/A
Completed NCT02909127 - The Pediatric Eating Assessment Tool
Not yet recruiting NCT06377982 - Human Umbilical Cord Blood Infusion in Patients With Cerebral Palsy Phase 1
Not yet recruiting NCT06007885 - Examining Capacity Building of Youth With Physical Disabilities to Pursue Participation Following the PREP Intervention. N/A
Not yet recruiting NCT03183427 - Corpus Callosum Size in Patients With Pineal Cyst N/A
Active, not recruiting NCT03078621 - Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy Phase 1/Phase 2